| Pazopanib |
ENSG00000031544.10 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000131484.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000132204.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000146666.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000149656.4 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000157306.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000157306.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000163364.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000175967.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000177757.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000177788.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000177822.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000178248.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000178440.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000178440.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000178440.5 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000178440.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000178803.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000178947.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000179447.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000179859.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000179859.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000180279.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000182109.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000182366.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000182873.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000184324.11 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000186019.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000187979.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000188206.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000189149.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000189223.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000189223.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000189223.9 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000189419.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000196553.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000196668.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000196668.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000196810.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000197291.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000197332.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000197558.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000197585.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000197813.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000198106.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000203279.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000203356.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000203497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000203506.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000203650.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000203721.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000203865.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000203875.6 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000203886.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000204044.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000204044.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000204241.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000204380.2 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000204802.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000204832.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000204860.4 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000204929.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000204949.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000205293.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000205424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000205662.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000205663.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000205885.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000205890.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000205890.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000206195.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000212163.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000213742.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000214353.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000214432.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000214650.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000214650.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000214772.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000214803.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000215039.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000215159.3 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000215304.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000215374.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000215386.6 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000215424.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000215458.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000215458.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000215458.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000215458.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000215769.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000215908.5 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000219410.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000220161.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000223379.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000223380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000223393.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000223403.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000223477.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000223537.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000223579.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000223598.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000223692.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000223764.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000223821.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000224078.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000224079.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000224100.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000224107.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000224239.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000224281.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000224356.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000224358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000224387.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000224387.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000224387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224429.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000224460.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000224509.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000224592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224597.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000224616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000224616.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000224660.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000224666.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224699.4 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000224733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224745.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000224746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000224761.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000224790.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000224817.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224933.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000224950.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000224965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000224985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000225037.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000225039.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000225063.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000225076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000225077.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000225092.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000225113.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000225138.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000225210.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000225439.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000225489.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000225518.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000225548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000225667.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000225675.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000225721.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000225721.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000225731.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000225750.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000225783.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000225806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000225822.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000225839.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000225889.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000225930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000225988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226091.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000226091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226155.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000226179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000226237.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000226272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000226377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000226386.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000226423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226496.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000226578.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000226648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226659.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000226684.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226786.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000226819.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000226856.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000226877.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000226913.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000226935.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000226944.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000227006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000227083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000227117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000227128.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227359.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000227374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227388.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000227392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227407.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000227432.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000227438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000227481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000227495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000227518.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227542.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000227555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227627.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000227637.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000227695.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000227698.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000227706.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000227726.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000227748.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000227773.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000227857.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000227888.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000227888.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000227896.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000227953.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000227953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000228035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000228043.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000228060.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000228060.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000228065.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000228126.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000228139.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000228141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000228153.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000228192.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000228192.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000228203.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000228237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000228242.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000228251.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000228288.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000228302.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000228317.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000228350.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000228352.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000228386.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000228397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000228397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000228414.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000228470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000228509.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000228526.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000228527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000228554.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000228630.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000228677.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000228682.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000228723.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000228742.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000228748.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000228775.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000228794.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000228839.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000228857.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000228889.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000228973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229111.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000229118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229154.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000229167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229195.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000229311.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000229315.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229325.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000229380.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000229393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229444.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000229463.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000229487.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000229502.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229611.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000229688.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229728.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000229776.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000229807.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000229832.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000229852.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000229869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000229893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229893.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000229952.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000229953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000229955.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000229956.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000229999.2 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000230005.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000230010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000230013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000230061.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000230091.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000230113.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000230148.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000230289.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000230290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000230303.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000230303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230333.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230333.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000230345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230366.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000230394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230438.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000230438.5 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000230487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230530.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000230537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230606.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000230612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230699.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000230729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000230735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230826.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000230834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000230898.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000230925.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000231064.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000231073.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000231081.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000231212.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000231227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000231233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000231327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000231327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000231465.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000231607.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000231616.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000231636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000231663.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000231704.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000231709.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000231711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000231769.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000231795.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000231842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000231865.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000231865.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000231881.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000231903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000231927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000231976.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000231993.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000232021.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000232065.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000232093.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000232093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000232116.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000232224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000232284.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000232300.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000232300.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000232342.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000232388.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000232412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000232504.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000232504.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000232527.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000232530.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000232530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000232611.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000232618.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000232623.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000232623.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000232656.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000232684.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000232684.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000232719.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000232729.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000232754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000232754.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000232811.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000232907.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000232909.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000232931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000232956.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000232995.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000233006.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000233016.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000233058.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000233060.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000233080.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000233086.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000233101.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000233144.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000233184.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000233242.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000233244.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000233246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000233250.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000233396.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000233483.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000233483.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000233602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000233625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000233627.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000233635.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000233643.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000233661.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000233695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000233695.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000233757.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000233757.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000233791.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000233791.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000233800.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000233817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000233825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000233885.3 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000233930.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000233937.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000234072.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000234084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000234141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000234148.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000234155.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000234185.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000234215.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000234222.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000234222.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000234245.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000234281.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000234292.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000234311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000234405.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000234405.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000234432.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000234449.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000234459.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000234492.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000234676.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000234684.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000234688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000234705.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000234705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000234773.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000234928.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000234996.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000235029.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000235078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000235111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000235159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000235204.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000235214.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000235277.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000235280.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000235296.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000235298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000235314.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000235335.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000235408.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000235445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000235527.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000235629.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000235635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000235726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000235806.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000235831.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000235903.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000235908.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000235910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000235919.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000235934.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000235958.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000236066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000236088.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000236153.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000236213.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000236255.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000236262.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000236266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000236308.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000236345.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000236426.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000236438.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000236449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000236472.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000236548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000236861.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000236896.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000236935.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000236935.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000236947.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000236983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000236986.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000237015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000237017.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000237027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237200.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000237208.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000237404.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000237416.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000237422.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000237424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237438.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000237461.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000237476.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000237512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237517.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237737.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000237773.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000237852.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237852.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000237853.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237879.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237883.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000237892.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000237899.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000237903.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000237975.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000237978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000237989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000238005.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000238018.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000238121.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000238133.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000239335.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000239446.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000239480.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000239593.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000239674.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000239677.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000239828.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000240050.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000240093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000240137.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000240254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000240373.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000240453.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000240661.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000240758.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000240770.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000240875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000240915.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000240922.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000241155.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000241481.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000241593.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000241764.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000241818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000241985.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000242049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000242082.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000242104.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000242125.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000242207.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000242282.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000242391.2 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000242569.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000242759.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000242973.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000243107.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000243107.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000243224.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000243230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000243485.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000243550.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000243795.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000243902.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000244124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000244252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000244286.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000244300.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000244306.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000244332.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000244332.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000244349.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000244380.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000244513.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000244676.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000244968.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000245112.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000245281.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000245330.4 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000245573.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000245719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000245750.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000245768.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000245768.2 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000245857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000245910.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000245937.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000246145.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000246263.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000246339.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000246451.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000246451.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000246465.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000246523.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000246889.2 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000246898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000247151.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000247213.2 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000247271.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000247363.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000247373.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000247735.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000248019.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000248100.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000248172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000248243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000248265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000248360.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000248399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000248473.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000248476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000248537.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000248587.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000248629.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000248790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000248866.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000248866.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000248996.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000249145.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000249359.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000249476.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000249509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000249599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000249604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000249609.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000249635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000249655.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000249684.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000249685.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000249825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000250027.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000250033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000250046.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000250057.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000250057.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000250069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000250101.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000250132.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000250156.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000250174.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000250241.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000250267.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000250295.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000250295.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000250326.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000250343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000250413.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000250421.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000250490.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000250548.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000250786.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000250820.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000250948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000250986.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000251018.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000251031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000251131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000251168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000251273.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000251364.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000251364.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000251555.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000251556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000251600.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000251603.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000251652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000251661.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000251661.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000253106.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000253112.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000253121.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000253167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000253167.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000253263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000253284.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000253284.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000253327.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000253361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000253406.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000253420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000253475.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000253562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000253563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000253669.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000253708.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000253744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000253796.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000253829.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000253848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000253878.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000253965.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000253972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000253978.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000254027.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000254034.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000254099.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000254099.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000254153.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000254153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000254166.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000254177.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000254263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000254286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000254319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000254341.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000254370.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000254370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000254389.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000254428.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000254459.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000254461.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000254468.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000254473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000254542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000254554.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000254602.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000254602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000254610.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000254620.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000254703.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000254744.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000254756.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000254837.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000254847.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000254907.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000254973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000254988.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000254990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000254991.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000255087.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000255089.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000255089.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000255139.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000255145.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000255153.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000255153.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000255182.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000255248.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000255328.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000255362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000255362.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000255418.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000255434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000255434.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000255458.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000255517.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000255521.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000255559.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000255559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000255618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000255717.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000255808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000255929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000255933.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000255983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000256196.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000256199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000256250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000256250.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000256268.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000256278.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000256299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000256299.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000256325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000256442.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000256481.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000256546.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000256576.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000256588.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000256603.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000256670.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000256721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000256802.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000256967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000257135.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000257151.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000257191.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000257270.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000257271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000257285.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000257285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000257474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000257509.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000257526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000257526.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000257534.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000257595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000257647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000257809.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000257809.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000257831.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000257913.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000258044.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000258048.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000258082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000258082.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000258099.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000258102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000258188.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000258199.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000258199.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000258260.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000258301.2 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000258303.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000258323.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000258325.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000258410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000258428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000258428.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000258428.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000258443.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000258458.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000258479.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000258479.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000258520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000258525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000258593.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000258603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000258612.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000258636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000258649.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000258667.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000258689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000258689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000258731.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000258819.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000258824.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000258949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000258957.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000258957.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000258999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000259002.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259062.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000259081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000259093.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000259118.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000259138.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000259163.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259238.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000259244.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000259254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259322.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000259362.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000259365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259422.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000259432.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000259439.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000259439.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000259448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259463.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000259469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259475.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000259540.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000259561.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000259595.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000259640.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000259652.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000259673.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000259673.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000259713.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000259757.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000259772.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000259782.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000259788.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000259792.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000259798.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000259798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000259818.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259834.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000259843.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259843.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000259865.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000259888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000259920.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000259921.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000259933.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000259953.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000259992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260018.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000260022.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000260022.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000260022.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000260035.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000260037.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000260046.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000260162.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000260188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260193.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260196.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000260261.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000260277.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000260278.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000260288.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000260293.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000260316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000260366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000260388.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000260392.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000260396.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260425.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000260439.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000260441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000260448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000260468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000260565.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260586.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000260588.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000260593.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000260618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000260625.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000260626.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000260641.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000260660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000260664.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000260698.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000260743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260750.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000260751.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000260792.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000260793.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000260803.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000260895.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000260907.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000260920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000260936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000260981.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000261060.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000261070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261114.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000261141.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000261158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261168.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000261183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000261185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261195.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000261231.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000261235.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000261270.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000261310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261327.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000261329.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000261338.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000261360.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000261372.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000261374.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000261392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000261404.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000261425.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000261431.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000261433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000261433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000261455.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000261476.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000261476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000261478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261496.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000261512.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000261534.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000261537.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000261542.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000261543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000261570.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000261654.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000261685.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000261693.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000261693.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000261716.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000261716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000261723.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000261801.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000261823.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000261879.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000261886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000261889.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000262001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000262001.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000262074.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000262202.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000262202.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000262222.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000262298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000262332.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000262339.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000262339.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000262410.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000262434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000262514.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000262580.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000262619.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000262686.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000262692.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000262692.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000263011.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000263015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000263098.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000263164.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000263167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000263214.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000263220.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000263272.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000263300.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000263316.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000263321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000263325.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000263388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000263427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000263466.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000263466.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000263508.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000263731.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000263786.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000263847.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000263862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000263924.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000263931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000263934.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000264207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000264365.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000264548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000264589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000264635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000264647.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000264745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000264769.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000264812.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000264860.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000265043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000265094.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000265130.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000265185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000265185.2 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000265519.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000265666.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000265688.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000265743.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000265749.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000265912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000265975.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000265975.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000265984.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000265987.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000266079.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000266261.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000266371.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000266371.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000266389.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000266389.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000266397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000266402.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000266473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000266521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000266579.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000266651.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000266801.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000266803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000266821.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000266821.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000266901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000266911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000266922.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000266934.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000266970.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000266975.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000266978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000266987.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000267003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000267016.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000267025.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000267040.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000267042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267042.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000267047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267108.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000267130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267141.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000267143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000267151.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000267163.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000267192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000267193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000267199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000267201.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000267212.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000267212.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000267212.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000267230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000267243.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000267246.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000267248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000267268.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000267272.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000267289.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000267298.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000267311.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000267342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000267372.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000267375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267474.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000267480.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000267481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000267481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000267493.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000267505.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000267532.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267549.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000267560.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000267588.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000267658.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000267659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267665.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267723.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000267731.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000267737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000267750.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000267765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267776.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000267786.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000267798.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000267808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000267874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000267919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000268015.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000268061.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000268066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000268087.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000268157.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000268230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000268362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000268366.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000268416.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000268564.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000268583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000268605.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000268707.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000268836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000268842.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000268895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000268938.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000269019.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000269091.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000269148.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000269161.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000269194.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000269235.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000269387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000269400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000269400.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000269425.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000269444.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000269463.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000269688.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000269737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000269815.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000269836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000269896.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000269903.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000269911.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000269911.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000269934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000269947.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000269996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000269996.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000270015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000270019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000270030.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270049.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000270074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000270093.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000270095.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000270100.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000270105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000270105.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000270115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270117.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000270133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000270137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000270141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000270143.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000270154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000270171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270177.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000270184.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000270190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270246.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000270332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000270332.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000270344.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000270361.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000270426.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000270641.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000270659.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000270659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270681.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000270720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000270720.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000270750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000270761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000270820.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000270876.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000270964.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000271119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000271156.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000271192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000271204.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000271265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000271270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000271347.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000271366.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000271367.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000271384.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000271398.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000271401.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000271643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000271734.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000271757.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000271757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000271761.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000271780.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000271788.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000271789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000271833.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000271843.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000271855.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000271862.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000271862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000271882.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000271912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000271913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000271913.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000271921.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000271926.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000271947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000271966.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000271973.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000271997.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000272003.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272010.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272024.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272040.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000272048.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000272071.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272079.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272103.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272103.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000272109.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272141.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272148.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272148.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272168.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000272209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000272217.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000272263.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Pazopanib |
ENSG00000272320.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000272361.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272370.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000272371.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000272377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000272389.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000272402.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272420.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272438.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272440.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000272498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272508.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272508.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000272524.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272529.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272556.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272564.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272564.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000272583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000272588.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272604.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000272609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000272650.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272669.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272688.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272696.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000272709.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Pazopanib |
ENSG00000272717.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272720.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000272733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000272761.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272763.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272777.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000272792.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000272800.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000272846.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272861.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272888.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000272894.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000272911.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000272954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000272977.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000272993.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000272993.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000272993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000272995.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000273001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000273004.1 |
Predicted lncRNA |
Sarcoma |
|
| Pazopanib |
ENSG00000273008.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000273009.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000273015.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Pazopanib |
ENSG00000273133.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000273160.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000273176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000273186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000273188.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000273190.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Pazopanib |
ENSG00000273230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000273237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000273240.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000273243.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000273245.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Pazopanib |
ENSG00000273290.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000273302.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000273313.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000273321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000273329.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Pazopanib |
ENSG00000273338.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Pazopanib |
ENSG00000273381.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Pazopanib |
ENSG00000273403.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000273403.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Pazopanib |
ENSG00000273447.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Pazopanib |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Pazopanib |
ENSG00000273483.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|